Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

Cadmium atom inhibits KCNQ3. 1 / 1

| 1

➶

reach

"In contrast, mutating the endogenous cysteine C106A in KCNQ2 S1 produced a significant decline in Cd 2+ inhibition of the C106A-R198C KCNQ2/WT KCNQ3 heteromer as compared with the Cd 2+ inhibitory effect on R198C KCNQ2/WT KCNQ3 or on R198C KCNQ2 and C136A KCNQ3 heteromers (XREF_TABLE and XREF_FIG, third row)."

25385787

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...